Encouragingly, Hsp90α has emerged as a promising target for drug development aimed at treating a range of diseases, including cancer and disorders linked to protein misfolding such as renal fibrosis, pulmonary fibrosis and other inflammatory diseases.21, 22, 23, 24, 25. Here, HSP90AA1 is linked to renal fibrosis.